Meibomian Gland Dysfunction (MGD) Clinical Trial
Official title:
Thermal Pulsation System for the Treatment of Meibomian Gland Dysfunction
The current study aims to test the efficacy of treatment for a device that utilises a
thermal pulsation system, which applies heat from the inner surface of the eyelids
(Lipiflow) in patients suffering from meibomian gland dysfunction.
Patients will be asked to undergo a one-time treatment with Lipiflow and the investigators
will monitor them for changes in tear film and lipid composition, as well as changes in the
anatomy of meibomian glands for over a study period of 12 weeks. Additionally, dry eye
symptoms will be documented in form of questionnaires.
The investigators hypothesize that the treatment will be effective in improving clinical
signs and will relieve dry eye symptoms for the patient. If this method of managing
Meibomian Gland Dysfunction (MGD) is found to be efficacious and safe, it will be made
available to patients in Singapore.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03972501 -
An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)
|
Phase 2 | |
| Completed |
NCT03708367 -
A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice
|
N/A | |
| Completed |
NCT02284997 -
The Effect of an Eyelid Warming Device for the Management of Meibomian Gland Dysfunction
|
N/A |